Articles from LambdaVision

LambdaVision, a biotech innovator leveraging microgravity to manufacture its investigational protein-based artificial retina to help patients regain sight lost to retinal degenerative diseases, has closed a $7M seed funding round co-led by Seven Seven Six and Aurelia Foundry Fund, with additional support from Seraphim Space, providing runway into 2027. Millions of people worldwide lose their sight each year to retinal degenerative diseases like retinitis pigmentosa (RP) and age-related macular degeneration (AMD), with few effective treatment options. The funding will advance preclinical development and scale up space-enabled manufacturing of its artificial retina.

LambdaVision, an innovative biotech company developing a protein-based artificial retina to help patients regain sight lost to retinal degenerative diseases, has been awarded a National Aeronautics and Space Administration (NASA) Phase 2 In Space Production Applications (InSPA) award. This NASA award will enable LambdaVision to further develop layer-by-layer manufacturing processes to support artificial retina production, while improving quality, scale, and GMP manufacturing practices in terrestrial and low-Earth orbit (LEO) environments. These efforts will move LambdaVision closer to IND-enabling studies on Earth, which will be followed by clinical trials for patients with advanced retinitis pigmentosa (RP).

LambdaVision, an innovative biotech company developing a protein-based artificial retina to help patients regain sight lost to retinal degenerative diseases, announced it secured the first closing of its seed round being led by Aurelia Foundry Fund, a fund spun out of MIT. The round also includes investment from Boryung, a publicly listed Korean pharmaceutical company, and E2MC Ventures. The targeted raise will fund LambdaVision’s GMP manufacturing scale up and critical IND-enabling efficacy and toxicity studies, advancing LambdaVision closer to clinical trials initially targeted for blind patients with advanced retinitis pigmentosa (RP).